This 21 year male, underwent excision of supra sellar SOL in October 07, 2021 presented with complaints of decrease peripheral vision since July 2021 & headache before surgery. Patient has no previous history of radiation & chemotherapy. On clinical examination young boy is sitting on chair comfortably has field defect on both sides. MRI brain with contrast dated January 13, 2022 shows abnormal signal intensity mass lesion seen in supra sellar region suggestive of craniopharyngioma. Histopathology dated October 10, 2021 shows craniopharyngioma. Pituitary hormones dated October 25, 2021 shows decrease cortisol level (0.09). February 08, 2022 shows elevated IGF-1 level (507.40). Risks of GKSRS have been explained. Written and valid consent obtained to proceed. They were agreed upon and they wish to proceed.
Follow-up Comparative Study after 6 months:
Patient
consulted the gamma knife center for first routine follow up presented with
recent MRI brain with contrast dated September 08, 2022 shows almost complete
resolution of previously targeted craniopharyngioma only tiny enhancing
residual seen when compared with previous MRI brain with contrast dated
February 15, 2022 suggestive of good response to therapy.
